TIMING TO MINIMALLY INVASIVE SURGERY AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR RECTAL CANCER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Per richiedere l’adesione al Trial inviare una email al seguente indirizzo:
TiMiSNAR@ospedale.al.it
Application for participation of International recruiting centers is available! Please email igor.monsellato@ospedale.al.it for more information!
Italiano